-
$262,000
0.09% of portfolio
-
Q1 2024
Reduced 4.4%
$308B
$258,000
0.09% of portfolio
4,050
Q1 2024
Reduced 4.71%
$39.3B
$248,000
0.09% of portfolio
510
Q4 2023
Added 2.62%
$133B
$242,000
0.08% of portfolio
1,135
Q4 2023
Added 51.33%
$153B
$238,000
0.08% of portfolio
1,050
Q2 2024
Reduced 1.41%
$16.1B
$235,000
0.08% of portfolio
575
Q4 2023
Reduced 6.66%
$0
$234,000
0.08% of portfolio
4,630
Q1 2024
New
$205B
$199,000
0.07% of portfolio
3,347
Q1 2024
Reduced 16.47%
$53.7B
$204,000
0.07% of portfolio
3,415
Q1 2024
Reduced 36.11%
$0
$200,000
0.07% of portfolio
2,675
Q4 2023
New
$93B
$198,000
0.07% of portfolio
1,450
Q1 2024
Reduced 3.97%
$49.1B
$195,000
0.07% of portfolio
12,004
Q4 2018
Added 23.75%
$14.7B
$208,000
0.07% of portfolio
1,200
Q3 2020
Reduced 25.0%
Ge Healthcare Technologies Inc Corp
-
$188,000
0.07% of portfolio
-
Q2 2024
Reduced 1.07%
$151B
$212,000
0.07% of portfolio
960
Q1 2023
Reduced 9.43%
-
$196,000
0.07% of portfolio
-
Q2 2024
New
$74.8B
$194,000
0.07% of portfolio
820
Q2 2024
Reduced 4.65%
$157B
$192,000
0.07% of portfolio
2,720
Q2 2024
Reduced 8.42%
$0
$175,000
0.06% of portfolio
2,260
Q4 2022
New
$271B
$177,000
0.06% of portfolio
1,129
Q4 2023
Added 9.72%
$0
$174,000
0.06% of portfolio
6,200
Q1 2024
New
$100B
$159,000
0.06% of portfolio
97
Q2 2024
Reduced 9.35%
$57.9B
$166,000
0.06% of portfolio
775
Q4 2021
Reduced 8.82%
$213B
$161,000
0.06% of portfolio
632
Q2 2024
Reduced 12.71%
-
$132,000
0.05% of portfolio
-
Q3 2023
Reduced 12.79%
$102B
$155,000
0.05% of portfolio
2,065
Q2 2024
Reduced 94.64%
$173B
$131,000
0.05% of portfolio
1,960
Q1 2021
Reduced 50.0%
$75.8B
$146,000
0.05% of portfolio
2,488
Q2 2024
Reduced 95.88%
$382B
$141,000
0.05% of portfolio
1,000
Q4 2023
Reduced 21.57%
$103B
$154,000
0.05% of portfolio
2,350
Q2 2023
Reduced 24.19%
$58.1B
$141,000
0.05% of portfolio
250
Q2 2024
Reduced 3.85%
$244B
$130,000
0.05% of portfolio
505
Q1 2024
Reduced 6.48%
$110B
$126,000
0.04% of portfolio
650
Q4 2023
Added 52.94%
$47.6B
$119,000
0.04% of portfolio
2,425
Q1 2023
Reduced 3.0%
$45.1B
$114,000
0.04% of portfolio
540
Q4 2022
Reduced 3.57%
$51.7B
$117,000
0.04% of portfolio
745
Q4 2023
New
$1.12T
$101,000
0.04% of portfolio
200
Q4 2022
Reduced 20.0%
$26.5B
$104,000
0.04% of portfolio
325
Q2 2023
Reduced 17.72%
$90B
$106,000
0.04% of portfolio
1,090
Q1 2024
Reduced 49.3%
$0
$101,000
0.04% of portfolio
1,100
Q1 2023
New
$50.1B
$109,000
0.04% of portfolio
680
Q2 2017
New
$93.5B
$128,000
0.04% of portfolio
430
Q2 2021
Added 186.67%
$35B
$96,000
0.03% of portfolio
1,058
Q3 2020
New
$240B
$97,000
0.03% of portfolio
550
Q2 2017
New
$22.6B
$89,000
0.03% of portfolio
4,200
Q1 2024
Reduced 5.62%
$43.5B
$80,000
0.03% of portfolio
355
Q4 2023
New
$2.38B
$76,000
0.03% of portfolio
1,400
Q4 2017
New
$29.3B
$94,000
0.03% of portfolio
750
Q1 2018
Reduced 6.25%
$72B
$75,000
0.03% of portfolio
597
Q2 2022
Reduced 20.08%
$39.6B
$82,000
0.03% of portfolio
1,010
Q3 2023
Reduced 5.61%